<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Dahal K</submitter><funding>NIAID NIH HHS</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>Small interfering RNAs (siRNAs) produced through the processing of viral double-stranded RNAs mediate potent antiviral RNA interference (RNAi) in eukaryotes. In &lt;i>Caenorhabditis elegans&lt;/i>, such an antiviral defense is further amplified through the production of secondary siRNAs, yet the mechanisms by which secondary virus-derived siRNAs (vsiRNAs) confer protection remain poorly understood. Here, we characterize the role of &lt;i>rsd-6&lt;/i>, which encodes a Tudor domain protein and plays important role in antiviral RNAi, in vsiRNA biogenesis and modulation of viral pathogenesis. Using CRISPR Cas9-generated &lt;i>rsd-6&lt;/i> null mutants, we show that both primary and secondary vsiRNAs accumulate normally in the absence of RSD-6, indicating that it functions downstream of secondary vsiRNA biogenesis. We further showed that secondary vsiRNAs generated in &lt;i>rrf-1&lt;/i>-independent manner remained detected in the absence of RSD-6 and viral replication is further enhanced in &lt;i>rrf-1;rsd-6&lt;/i> double mutants compared to &lt;i>rrf-1&lt;/i> single mutants, suggesting a role of &lt;i>rsd-6&lt;/i> in mediating antiviral guided by all secondary vsiRNAs. Consistently, &lt;i>rsd-6&lt;/i> mutants exhibited more severe pathogenesis upon Orsay virus infection compared to &lt;i>rrf-1&lt;/i> mutants, underscoring its role as a major determinant of viral disease outcome. Domain characterization established that the N-terminal tandem domains of RSD-6 are required for antiviral activity, while the C-terminal Tudor domains are dispensable. Functional conservation was confirmed in &lt;i>C. briggsae&lt;/i>, where silencing of the &lt;i>rsd-6&lt;/i> homolog enhanced viral replication. Together, our findings identify RSD-6 as a key effector acting downstream of secondary vsiRNA production and highlight its conserved role in modulating viral replication and pathogenesis across &lt;i>Caenorhabditis&lt;/i> species.</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2025.09.02.673749</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12424992</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Characterizing the role of RSD-6 in the biogenesis of virus-derived small interfering RNAs and the modulation of viral pathogenesis.</pubmed_title><pmcid>PMC12424992</pmcid><funding_grant_id>R01 GM119012</funding_grant_id><funding_grant_id>R03 AI171860</funding_grant_id><pubmed_authors>Dahal K</pubmed_authors><pubmed_authors>Xia M</pubmed_authors><pubmed_authors>Lu J</pubmed_authors><pubmed_authors>Yan T</pubmed_authors><pubmed_authors>Lu R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterizing the role of RSD-6 in the biogenesis of virus-derived small interfering RNAs and the modulation of viral pathogenesis.</name><description>Small interfering RNAs (siRNAs) produced through the processing of viral double-stranded RNAs mediate potent antiviral RNA interference (RNAi) in eukaryotes. In &lt;i>Caenorhabditis elegans&lt;/i>, such an antiviral defense is further amplified through the production of secondary siRNAs, yet the mechanisms by which secondary virus-derived siRNAs (vsiRNAs) confer protection remain poorly understood. Here, we characterize the role of &lt;i>rsd-6&lt;/i>, which encodes a Tudor domain protein and plays important role in antiviral RNAi, in vsiRNA biogenesis and modulation of viral pathogenesis. Using CRISPR Cas9-generated &lt;i>rsd-6&lt;/i> null mutants, we show that both primary and secondary vsiRNAs accumulate normally in the absence of RSD-6, indicating that it functions downstream of secondary vsiRNA biogenesis. We further showed that secondary vsiRNAs generated in &lt;i>rrf-1&lt;/i>-independent manner remained detected in the absence of RSD-6 and viral replication is further enhanced in &lt;i>rrf-1;rsd-6&lt;/i> double mutants compared to &lt;i>rrf-1&lt;/i> single mutants, suggesting a role of &lt;i>rsd-6&lt;/i> in mediating antiviral guided by all secondary vsiRNAs. Consistently, &lt;i>rsd-6&lt;/i> mutants exhibited more severe pathogenesis upon Orsay virus infection compared to &lt;i>rrf-1&lt;/i> mutants, underscoring its role as a major determinant of viral disease outcome. Domain characterization established that the N-terminal tandem domains of RSD-6 are required for antiviral activity, while the C-terminal Tudor domains are dispensable. Functional conservation was confirmed in &lt;i>C. briggsae&lt;/i>, where silencing of the &lt;i>rsd-6&lt;/i> homolog enhanced viral replication. Together, our findings identify RSD-6 as a key effector acting downstream of secondary vsiRNA production and highlight its conserved role in modulating viral replication and pathogenesis across &lt;i>Caenorhabditis&lt;/i> species.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T03:13:11.566Z</modification><creation>2026-06-03T03:10:37.405Z</creation></dates><accession>S-EPMC12424992</accession><cross_references><pubmed>40950003</pubmed><doi>10.1101/2025.09.02.673749</doi></cross_references></HashMap>